ArticleScientific reports2022

Molecular subtype conversion in CTCs as indicator of treatment adequacy associated with metastasis-free survival in breast cancer.

E S Grigoryeva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.